Cargando…

Review of the Processes for FDA Oversight of Drugs, Medical Devices, and Combination Products

Detalles Bibliográficos
Autores principales:	Sweet, Burgunda V., Schwemm, Ann K., Parsons, Dawn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437518/ https://www.ncbi.nlm.nih.gov/pubmed/21204589 http://dx.doi.org/10.18553/jmcp.2011.17.1.40

Ejemplares similares

FDA oversight of medical devices
por: Hill, Matthew W, et al.
Publicado: (2012)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

FDA oversight of NSIGHT genomic research: the need for an integrated systems approach to regulation
por: Milko, Laura V., et al.
Publicado: (2019)

Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs
por: Van Norman, Gail A.
Publicado: (2016)

Cybersecurity features of digital medical devices: an analysis of FDA product summaries
por: Stern, Ariel Dora, et al.
Publicado: (2019)

Medical device regulation and oversight in African countries: a scoping review of literature and development of a conceptual framework
por: Nasir, Naima, et al.
Publicado: (2023)

Monitoring and oversight in critical care research
por: Lavery, James V, et al.
Publicado: (2004)

Testosterone therapy in the new era of Food and Drug Administration oversight
por: Desroches, Bethany, et al.
Publicado: (2016)

Regulatory oversight and ethical concerns surrounding software as medical device (SaMD) and digital twin technology in healthcare
por: Lal, Amos, et al.
Publicado: (2022)

Rigorous review and editorial oversight of clinical preprints
por: Zaidi, Mone, et al.
Publicado: (2021)

Managed Care Perspective on Three New Agents for Type 2 Diabetes
por: VanDeKoppel, Shawna, et al.
Publicado: (2008)

The Trouble With Too Much Board Oversight
por: Hoitash, Udi
Publicado: (2013)

Regulatory Oversight and Safety of Probiotic Use
por: Venugopalan, Veena, et al.
Publicado: (2010)

COVID-19 vaccine development, production and regulatory oversight in African countries
por: Makenga, Geofrey, et al.
Publicado: (2022)

Processes for Scientific and Ethical Approval of Research Proposals: Better Oversight May Be Necessary
por: Andrade, Chittaranjan, et al.
Publicado: (2020)

Pharmacy Phamilies as a Component of a Co-Curricular Program for Doctor of Pharmacy Students
por: Mason, Nancy A., et al.
Publicado: (2020)

Mining FDA drug labels for medical conditions
por: Li, Qi, et al.
Publicado: (2013)

New Visualization Models of Designation Pathway and Group Categorization of Device–Drug and Device–Biologic Combination Products Classification in the United States: Analysis of FDA Capsular Decisions
por: Uemura, Nobuo, et al.
Publicado: (2021)

Additively manufactured medical products – the FDA perspective
por: Di Prima, Matthew, et al.
Publicado: (2016)

Oversights, Confusions and Misinterpretations Related to Self-Care and Medication in Diabetic and Renal Patients
por: Mira, José J., et al.
Publicado: (2014)

Bringing Opportunity Oversight Onto the Board's Agenda
por: Leonard, Frank
Publicado: (2013)

Corporate governance, board oversight, and CEO turnover
por: Laux, Volker
Publicado: (2014)

Four Fallacies and an Oversight: Searching for Martian Life
por: Rummel, J.D., et al.
Publicado: (2017)

US federal oversight of biological materials and the IBC
por: Howard, Deborah
Publicado: (2016)

Oversight and Management of Women with Psoriasis in Childbearing Age
por: Bucur, Ștefana, et al.
Publicado: (2022)

Genetic Regulation of Mitosis–Meiosis Fate Decision in Plants: Is Callose an Oversighted Polysaccharide in These Processes?
por: Somashekar, Harsha, et al.
Publicado: (2023)

Security and Privacy Qualities of Medical Devices: An Analysis of FDA Postmarket Surveillance
por: Kramer, Daniel B., et al.
Publicado: (2012)

Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy
por: Pinkerton, JoAnn V., et al.
Publicado: (2016)

Recall Rates of Total Knee Arthroplasty Devices Are Dependent on the FDA Approval Process
por: Pellerin, Carl, et al.
Publicado: (2020)

Impact of Automated Genotyping and Increased Breeding Oversight on Overall Mouse Breeding Colony Productivity
por: VanDenBerg, Kelly R., et al.
Publicado: (2022)

Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer
por: Yang, Liyan, et al.
Publicado: (2021)

Oversight Without Obstruction: The Challenge for High-Containment Labs
por: Manuel, John
Publicado: (2008)

Editorial: Oversight needed for new, far-reaching science
Publicado: (2008)

Cardiac arrhythmia in Wilson's disease: An oversighted and overlooked entity!
por: Bajaj, Bhupender Kumar, et al.
Publicado: (2016)

The Global Fund’s paradigm of oversight, monitoring, and results in Mozambique
por: Warren, Ashley, et al.
Publicado: (2017)

Oversight in Surgical Innovation: A Response to Ethical Challenges
por: Gupta, Saksham, et al.
Publicado: (2018)

Is it time to reform oversight of clinical gene therapy in the EU?
por: Kenter, Marcel J.H.
Publicado: (2018)

Research ethics oversight in Norway: structure, function, and challenges
por: Froud, R., et al.
Publicado: (2019)

Re: “The next phase of human gene-therapy oversight”
por: Yamato, Masayuki
Publicado: (2019)

Tigers, black swans, and unicorns: The need for feedback and oversight
por: Houck, Max M.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7tk4ubg0830dipq43gl231fr4c